Bioventus has entered an agreement to acquire Misonix for $518 million in a cash-and-stock transaction.
The Latest
A study found that preoperative cold treatment can reduce opioid intake and pain scores in total knee replacement patients during a six-week recovery period.
Smith+Nephew posted growth in all segments of its orthopedics business in the second quarter.
Buffalo, N.Y.-based Kaleida Health is the latest organization to join a class-action lawsuit that accuses Intuitive Surgical of antitrust behavior and a monopoly position related to its da Vinci surgical robot, Buffalo Business First reports.
Medical device company MirRus raised $65 million in a round of funding for its Rhenium-based spine devices and heart disease treatment development, the company said July 27.
The number of orthopedic and total joint replacement cases is expected to rise, according to Richard Berger, MD.
Spine-facing medical technology company Carlsmed is collaborating with the International Spine Study Group Foundation to collect surgical data on personalized interbody devices.
A physician appointed to a board of trustees in Florida and nine more spine surgeons to know:
CMS has proposed several changes for 2022, with plans to halt the elimination of the inpatient-only list and return 298 musculoskeletal services back to the list being the most significant changes that would affect orthopedic care.
NuVasive's net sales in the second quarter increased 44.8 percent year over year to $294.8 million, and clinical evaluations of its Pulse spine system got underway in Europe.